Atomistry » Sodium » PDB 3epz-3f9l » 3f66
Atomistry »
  Sodium »
    PDB 3epz-3f9l »
      3f66 »

Sodium in PDB 3f66: Human C-Met Kinase in Complex with Quinoxaline Inhibitor

Enzymatic activity of Human C-Met Kinase in Complex with Quinoxaline Inhibitor

All present enzymatic activity of Human C-Met Kinase in Complex with Quinoxaline Inhibitor:
2.7.10.1;

Protein crystallography data

The structure of Human C-Met Kinase in Complex with Quinoxaline Inhibitor, PDB code: 3f66 was solved by C.Meier, T.Ceska, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 20.00 / 1.40
Space group P 1
Cell size a, b, c (Å), α, β, γ (°) 47.377, 47.587, 75.600, 100.70, 103.62, 98.29
R / Rfree (%) 16.8 / 22.5

Other elements in 3f66:

The structure of Human C-Met Kinase in Complex with Quinoxaline Inhibitor also contains other interesting chemical elements:

Fluorine (F) 6 atoms

Sodium Binding Sites:

The binding sites of Sodium atom in the Human C-Met Kinase in Complex with Quinoxaline Inhibitor (pdb code 3f66). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Human C-Met Kinase in Complex with Quinoxaline Inhibitor, PDB code: 3f66:

Sodium binding site 1 out of 1 in 3f66

Go back to Sodium Binding Sites List in 3f66
Sodium binding site 1 out of 1 in the Human C-Met Kinase in Complex with Quinoxaline Inhibitor


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Human C-Met Kinase in Complex with Quinoxaline Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Na6

b:34.9
occ:1.00
O B:HOH289 2.2 31.7 1.0
O B:PHE1134 2.4 29.4 1.0
O B:HOH201 2.5 26.8 1.0
O B:HOH155 2.5 40.9 1.0
O B:LYS1132 2.6 31.3 1.0
O B:HOH280 2.7 45.3 1.0
C B:PHE1134 3.6 26.7 1.0
C B:LYS1132 3.7 28.9 1.0
CB B:SER1135 4.2 28.1 1.0
NZ B:LYS1132 4.2 36.0 1.0
O B:MET1131 4.3 32.2 1.0
N B:PHE1134 4.4 27.5 1.0
O B:HOH30 4.4 27.3 1.0
CA B:SER1135 4.4 26.3 1.0
CA B:LYS1132 4.4 31.5 1.0
OG B:SER1141 4.5 19.7 0.5
CB B:SER1141 4.5 24.7 0.5
N B:SER1135 4.5 21.8 1.0
O B:LEU1142 4.5 26.9 1.0
C B:ASP1133 4.5 32.1 1.0
OG B:SER1135 4.6 28.2 1.0
N B:ASP1133 4.6 32.3 1.0
CA B:PHE1134 4.6 27.4 1.0
N B:LEU1142 4.6 25.8 1.0
CB B:SER1141 4.7 20.9 0.5
CA B:ASP1133 4.8 35.0 1.0
O B:HOH58 4.8 21.8 1.0
CD B:LYS1132 4.8 35.3 1.0
CA B:SER1141 4.8 23.0 0.5
CA B:SER1141 4.9 20.7 0.5
O B:ASP1133 4.9 35.5 1.0

Reference:

J.Porter, S.Lumb, F.Lecomte, J.Reuberson, A.Foley, M.Calmiano, K.Le Riche, H.Edwards, J.Delgado, R.J.Franklin, J.M.Gascon-Simorte, A.Maloney, C.Meier, M.Batchelor. Discovery of A Novel Series of Quinoxalines As Inhibitors of C-Met Kinase. Bioorg.Med.Chem.Lett. V. 19 397 2009.
ISSN: ISSN 0960-894X
PubMed: 19059779
DOI: 10.1016/J.BMCL.2008.11.062
Page generated: Tue Dec 15 06:10:23 2020

Last articles

Zn in 7VD8
Zn in 7V1R
Zn in 7V1Q
Zn in 7VPF
Zn in 7T85
Zn in 7T5F
Zn in 7NF9
Zn in 7M4M
Zn in 7M4O
Zn in 7M4N
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy